GlassScriptAdmedus Corporation
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$177Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
32clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Paul Sorajja | Phoenix, AZ | Interventional Cardiology | $101,000.00 |
| Alan Zajarias | Saint Louis, MO | Interventional Cardiology | $14,000.00 |
| Susheel Kodali | New York, NY | Interventional Cardiology | $12,000.00 |
| Gorav Ailawadi | Ann Arbor, MI | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $12,000.00 |
| Michael Reardon | Houston, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $8,000.00 |
| Christopher Meduri | Atlanta, GA | Interventional Cardiology | $8,000.00 |
| Samir Kapadia | Cleveland, OH | Cardiovascular Disease | $6,000.00 |
| Shelly Reardon | Austin, TX | Neurology With Special Qualifications In Child Neurology | $4,000.00 |
| Justin Nelms | Glen Burnie, MD | Vascular Surgery | $2,500.00 |
| Peter Henke | Ann Arbor, MI | Vascular Surgery | $2,375.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.